Together we will beat cancer


The pancreas is a gland that produces digestive juices and hormones like insulin. Around 10,000 people are diagnosed with pancreatic cancer in the UK each year, making it the 11th most common cancer in the UK.

Why consistent and funded cancer policies are key to improving cancer survival

Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types

Read More

‘Never done before’ AI study could improve early detection of pancreatic cancer

Around 8 in 10 pancreatic cancer cases are currently diagnosed late in England and Wales.

Read More

Scientists develop new precision medicine approach for pancreatic cancer

Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer. 

Read More

Cancer Research UK and AstraZeneca’s new antibody maturation technique yields high-affinity Arginase 2 antibody

Researchers in Cambridge have pioneered the development of an innovative affinity maturation technique to generate high-affinity antibody against Arginase 2.

Read More

Pancreatic cancer cells use the same energy as sprinters’ muscles to spread

Our scientists are using hydrogels to understand more about how pancreatic cancer cells spread.

Read More

Urine tests: detecting cancer in pee

This entry is part 2 of 4 in the series Detecting cancer early

We speak to our scientists who are developing urine tests that aim to detect bladder and pancreatic cancer earlier.

Read More

Cardiff scientist awarded £373k to find new ways to diagnose pancreatic cancer earlier

Dr Catherine Hogan has been funded by Cancer Research UK’s Early Detection Committee to understand pancreatic cancer cells and develop new diagnostic tools.

Read More

Makeup of bacteria in pancreatic tumours linked to survival

US researchers have found a link between the makeup of bacteria in the tumours of people with pancreatic cancer and how long they live.

Read More

Targeted drug trial points to potential ‘new age’ for pancreatic cancer treatment

A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.

Read More

Cancer Research UK to test targeted drug in pancreatic cancer

A dual kinase inhibitor is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine.

Read More